Research Article
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
Figure 2
18F-FCH PET/CT images of a mCRPC patient (73 years old) who underwent prostatectomy and obtained a CMR to docetaxel treatment. Baseline (a– c) and post-treatment (d–f) images. Maximum intensity projection images (a, d), transaxial slice of PET images (b, e), and PET/CT images (c, f) showing a metastasis in the left iliac bone (arrows) before docetaxel treatment: SUVmax = 14.6 g/ml (c); after treatment, metastasis disappeared.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |